Lead Investigator: Joo Sang Lee, Samsung Medical Center, South Korea
Title of Proposal Research: Harnessing genetic interactions to advance precision cancer medicine.
Vivli Data Request: 5096
Funding Source: Employment Contracts – The proposed research is funded by the cross-institutional collaboration grant between Samsung Medical Center and Sungkyunkwan University.
Potential Conflicts of Interest: None.
Summary of the Proposed Research:
Current precision oncology approaches are mainly resorting to genome sequencing data, aiming to identify actionable mutations. Here we introduce a complementary approach by incorporating the transcriptomics data to advance precision cancer medicine. We analyze large-scale cancer genomics/transcriptomics data collected in the public domain (n>15,000) and use them to guide the treatments for individual patients based on their genomics/transcriptomic profiles.
Integrated genomic profiling expands clinical options for cancer patients
Sponsor: Tempus Labs, Inc.
Study ID: T19.01